Gabapentin: A unique anti-epileptic agent

Neurological Research

Volumn 23, Issue 8, 2001, Pages 821-829

  Dougherty, J A ^a,b   Rhoney, D H ^a,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

^c DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

Anti epileptic drug; Epilepsy; Gabapentin; Neuropathic pain; Pharmacokinetics; Seizure

Indexed keywords

GABAPENTIN;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; EDEMA; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; SIDE EFFECT; TREATMENT INDICATION;

ACETIC ACIDS; ADULT; AMINES; ANTICONVULSANTS; CHILD; CYCLOHEXANECARBOXYLIC ACIDS; EPILEPSY, COMPLEX PARTIAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA;

EID: 0035191623     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164101101199414     Document Type: Article

References (44)

1. Clinical pharmacokinetics of gabapentin
2. Gabapentin: Pharmacokinetics, efficacy, and safety
3. Gabapentin
4. Gabapentin: A new agent for the management of epilepsy
5. A summary of mechanistic hypotheses of gabapentin pharmacology
6. Emerging perspectives on the mechanism of action of gabapentin
7. Gabapentin as an anti-epileptic drug in man
8. Gabapentin in the treatment of drug-resistant epileptic patients
9. Double-blind study of gabapentin in the treatment of partial seizures
10. Gabapentin in partial epilepsy
11. Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled, parallel-group study
12. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: A double-blind, placebo-controlled study
13. Outcome evaluation of gabapentin as add-on therapy for partial seizures
14. Dosing to efficacy with Neurontin: The STEPS Trial
15. A 26 week, double-blind, dose-controlled, multi-center study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures
16. Gabapentin monotherapy: An 8 day, double-blind, dose-controlled, multi-center study in hospitalized patients with refractory complex partial or secondarily generalized seizures
17. A double-blind trial of gebapentin monotherapy for newly diagnosed partial seizures
18. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy
19. Gabapentin in generalized seizures
20. Efficacy of gabapentin therapy in children with refractory partial seizures
21. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability
22. Gabapentin as add-on therapy in children with refractory partial seizures: A 12-week, multi-centre, double-blind, placebo-controlled study
23. Gabapentin in childhood epilepsy: A prospective evaluation of efficacy and safety
24. Gabapentin in naíve childhood absence epilepsy: Results from two double-blind, placebo-controlled, multi-center studies
25. Behavioral side effects of gabapentin in children
26. Gabapentin associated with aggressive behavior in pediatric patients with seizures
27. Gabapentin toxicity in children manifesting as behavioral changes
28. Gabapentin adjunctive therapy in neuropathic pain states
29. Gabapentin and neuropathic pain states: A case series report
30. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus
31. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain
32. Gabapentin for the treatment of postherpetic neuralgia
33. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain
34. Gabapentin for treatment of pain and tremor: A large case series
35. Gabapentin bioavailability: Effect of dose and frequency of administration in adult patients with epilepsy
36. Important pharmacokinetic properties of anti-epileptic drugs
37. Oral gabapentin disposition in patients with epilepsy after a high-protein meal
38. Failure of absorption of gabapentin after rectal administration
39. Lack of serious toxicity following gabapentin overdose
40. Gabapentin and cognition: A double-blind, dose ranging, placebo-controlled study in refractory epilepsy
41. Effects on gabapentin on cognition and quality of life in patients with epilepsy
42. High dose gabapentin in refractory partial epilepsy: Clinical observations in 50 patients